AlphaYouTWST: Laponis Adam discloses a sale
By AlphaYouPublished Form 4
Laponis Adam
Reporting filer
Laponis Adam reported Sale in Twist Bioscience Corp: 8057 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Laponis Adam | 2026-10-02 | S | Sale | 8057 | 188.884 | 100,576 | 3 days | Filed terms
|
Common Stock
- Owner
- Laponis Adam
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 8057
- Price
- 188.884
- Following holdings
- 100,576
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Timeliness:
- transaction Shares: 8057
- id: F1
- transaction Price Per Share: 188.884
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 100576
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Laponis Adam: Chief Financial Officer.
- F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.